...
...
Next Story

DGHS advisory drops all medicines from revised Covid management guidelines

It added stressed on healthy balanced diet with proper hydration, and asked patients and their families to stay connected and engage in positive talks through phone, video-calls, etc.

Updated on: Jun 7, 2021, 07:06:57 IST
By , Hindustan Times, New Delhi
Prefer HTon Google
Advertisement

The Union health ministry’s directorate general of health services (DGHS) has overhauled Covid-19 treatment guidelines and removed all medicines, except antipyretic (fever) and antitussive (cold), for asymptomatic and mild cases.

For tests, the advisory said, “Usually, no investigation is required at this stage.”
For tests, the advisory said, “Usually, no investigation is required at this stage.”

The revised guidelines, issued on May 27, effectively dropped all drugs that doctors have been prescribing even to asymptomatic or mildly symptomatic Covid-19 patients such as hydroxychloroquine, ivermectin, doxycycline, zinc, multivitamins etc. The guidelines also dissuade medical practitioners to prescribe unnecessary tests such as CT scan.

For asymptomatic cases, the guidelines said, no medication is required, while medications for other co-morbid conditions should be continued. “Patients are advised to seek tele consultation; and Covid-19 appropriate behaviour must be observed such as mask, strict hand hygiene and physical distancing,” the guidelines said.

It added stressed on healthy balanced diet with proper hydration, and asked patients and their families to stay connected and engage in positive talks through phone, video-calls, etc.

For tests, the advisory said, “Usually, no investigation is required at this stage.”

 
ABOUT THE AUTHOR
Rhythma Kaul

Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.

Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather major national developments and Karnataka Bandh LIVE.
Get the latest India News, breaking headlines and real-time updates from across the country. Stay informed about politics, government policies, crime, weather major national developments and Karnataka Bandh LIVE.
SHARE THIS ARTICLE ON
Hindustantimes wants to start sending you push notifications. Click allow to subscribe